| Literature DB >> 29510494 |
Noelia Clemente Plaza1, Manuel Reig García-Galbis2, Rosa María Martínez-Espinosa3.
Abstract
This review summarizes recent knowledge about the use of the amino acid l-Cysteine (l-Cys) through diet, nutritional supplements or drugs with the aim to improve human health or treat certain diseases. Three databases (PubMed, Scopus, and Web of Science) and different keywords have been used to create a database of documents published between 1950 and 2017 in scientific journals in English or Spanish. A total of 60,885 primary publications were ultimately selected to compile accurate information about the use of l-Cys in medicine and nutritional therapies and to identify the reported benefits of l-Cys on human health. The number of publications about the use of l-Cys for these purposes has increased significantly during the last two decades. This increase seems to be closely related to the rise of nutraceutical industries and personalized medicine. The main evidence reporting benefits of l-Cys usage is summarized. However, the lack of accurate information and studies based on clinical trials hampers consensus among authors. Thus, the debate about the role and effectiveness of supplements/drugs containing l-Cys is still open.Entities:
Keywords: ">l-cysteine; biological medicine; dietary supplements; nutraceutical; nutritional therapy
Mesh:
Substances:
Year: 2018 PMID: 29510494 PMCID: PMC6017824 DOI: 10.3390/molecules23030575
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure (a) and structural model (b) of an l-cysteine molecule (adapted from [1]).
Figure 2Summary of cysteine metabolism [8].
Figure 3Number of publications per year (January 1950–December 2017). Database: PubMed. Keyword: l-Cysteine.
Number of publications included in the database for this work (Database: PubMed). * %: calculated over the total number of publications compiled from each combination of keywords.
| Keywords | Total of Publications | Publications in the Last 5 Years (%)* |
|---|---|---|
| 52,873 | 9976 (19%) | |
| 4742 | 1725 (36%) | |
| 1891 | 579 (31%) | |
| 1074 | 265 (25%) | |
| 305 | 127 (42%) |
Summary of the potential effects of l-Cys (alone) supported by studies based on clinical trials.
| Examples of | Effects | Ref. |
|---|---|---|
| Nutritional therapy in children with severe edematous malnutrition | Restoration of the rate of synthesis and the concentration of glutathione during the first phase of treatment | [ |
| Scarring of the cornea after a photoreactive keratectomy | Reduced average time of scarring | [ |
| Nutritional therapy in Ictus patients | Reduced risk of cardiovascular accident | [ |
| Hair care | Reduced hair loss and increased hair strengthening abilities | [ |
| Protection of digestive system | Reduction in the concentration of acetaldehyde by avoiding exposure in cases of achlorhydria | [ |
| Treatment chronic inflammation | Increased antioxidant status | [ |
| Prevention of upper digestive tract cancer and breast cancer | Decrease of acetaldehyde in saliva or it can be used as part of metabolic starvation therapy | [ |
| Indicator for the control of cardiovascular diseases | Pro-inflammatory signaling | [ |
| Treatment of erythropoietic porphyria | Photosensitivity improvement | [ |
| Treatment of type-2 diabetes | Control of glycaemia and vascular inflammation | [ |
Summary of the potential effects of l-Cys (combined with other compounds) supported by studies based on clinical trials.
| Composition of the Mixture | Examples of Usage | Effects | Ref. |
|---|---|---|---|
| Nutritional therapy in elderly HIV + patients | Improved oxidation of carbohydrates, insulin sensitivity and body composition | [ | |
| Treatment of oxidative stress during aging | Increased synthesis of glutathione and decreases oxidative stress levels | ||
| Treatment of hypostatic ulcer | Reduced pain and improved degree of ulcer healing | [ | |
| Treatment of patients with type-2 diabetes | Increased levels of glutathione and decreased levels of triglycerides | [ | |
| Treatment of corneal epithelium after photoreactive keratectomy in patients affected by myopia | Reduced time of resurfacing corneal. | [ | |
| Improvement of well-trained athletes’ performance | Restoration of the attenuation of the activity of Natural Killer cells | [ |
Figure 4Chemical structure of N-acetyl-l-cysteine (NAC).
Summary of the potential effects of NAC supported by studies based on clinical trials.
| Examples of usage | Effects | Ref. |
|---|---|---|
| Treatment of methamphetamine-dependent patients | Methamphetamine dependence decreases | [ |
| Performance of athletes undergoing strenuous physical training | Redox equilibrium and adaptation processes improve | [ |
| Treatment of Thalassemia | Oxidative stress and DNA damage decrease | [ |
| Protection against the carcinogenic effect of tobacco | Modulation of biomarkers associated with cancer | [ |
| Treatment of bacterial meningitis | Antioxidant role | [ |
| Treatment against influenza virus | Proliferation of the virus is inhibited | [ |
| Mucolytic expectorant and treatment of respiratory tract infections | The viscosity decreases and facilitates the removal of mucus | [ |
| Specific antidote for acetaminophen overdose | Regeneration of glutathione levels | [ |
| Cardiovascular complications in patients with diabetes | Attenuation of cardiovascular complications | [ |
| Prevention of cardiovascular diseases | Reduction of plasma concentrations and homocysteine levels | [ |
| Treatment of chronic hepatitis C | Increase in glutathione and improvement in response to treatment with interferon | [ |
| Treatment of patients with acute liver failure | Reduced IL-17 levels | [ |
| Treatment of nephropathic cystinosis | Reduced oxidative stress and improved renal function | [ |
| Treatment of noise-induced hearing loss | Protective effect. Hearing loss is reduced | [ |
| Treatment of cocaine addiction | It acts as an anti-relapse agent in abstinent subjects | [ |